| Takeda Pharma AG - Entyvio subkutan 108 mg, Injektionslösung in einer Fertigspritze |
| 67537 | | 01 | | Entyvio subkutan 108 mg | | Injektionslösung in einer Fertigspritze | | L04AA33 | | Vedolizumab | | 16.10.2020 | | |
|
| Composition |
| vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Vedolizumabum | 108mg / 0.68ml |
| | BAG: Active Agent | Dose |
|---|
| Vedolizumabum | 108 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Arginine Hydrochloride | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Citras Dihydricus | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 544.26 | 608.35 | A | SL | Yes |
|
